Sugammadex provide better surgical condition and faster reversal of rocuronium-induced neuromuscular blockade compared with neostigmine on the patients undergoing laparoscopic surgery.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0001090

Enrollment

Registered

2014-04-28

Start date

2013-09-25

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : We randomly assigned double blinded two groups, group N(TOF count 1-2) and group S(PTC count 1-2). Moderate block group gives reverse drug commonly used dose while deep block group gives sugamm

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Scheduled general anesthesia patient who recieving laparoscopic cholecystectomy and diagnosing chronic cholecystitis, gall bladder polyp. 2) American Society of Anesthesiologists class 1-2.

Exclusion criteria

Exclusion criteria: 1) Patient, taking the drug which affect to muscle relaxant 2) The patient who renal, hepatic, lung dysfunction 3) Pregnancy 4) The patient who allergic reaction to intraoperative using drug 5) BMI 29.9 kg/m2 6) Upper abdomen surgical history 7) Pastmedical history of malignant hyperthermia 8) Severe inflammation of acutecholecystitis

Design outcomes

Primary

Measure	Time frame
Increasement of intra abdominal pressure	—

Secondary

Measure	Time frame
Surgical condition score;Time for to Train of four ratio 0.9(sec);Total consumption of muscle relaxant ;Shoulder tip pain	—

Countries

Korea, Republic of

Contacts

Public ContactBON WOOK KOO

Seoul National University Bundang Hospital

Outcome results